Following disruption in the bio/pharmaceutical supply chain as a result of the COVID pandemic, the outsourcing industry has learned to adapt and push forward in a climate that is dynamically different.
Following disruption in the bio/pharmaceutical supply chain as a result of the COVID pandemic, the outsourcing industry has learned to adapt and push forward in a climate that is dyamically different. In this Drug Solutions podcast episode, Pharmaceutical Technology® spoke with Gil Roth, president of the Pharma & Biopharma Outsourcing Association (PBOA), and Tara Dougal, content director, Pharma portfolio, Informa Markets, on the current challenges facing the outsourcing industry today as well how contract service providers are tackling sustainability and other big trends in the industry.
Gil Roth is the founder and president of the Pharma & Biopharma Outsourcing Association (PBOA), a non-profit trade group advocating for the regulatory, legislative, and general business interests of the contract manufacturing organization/contract development and manufacturing organization (CMO/CDMO) sector. He was the founding editor of Contract Pharma magazine. He can be reached at gil.roth@pharma-bio.org.
Tara Dougal is content director for the Pharma portfolio at Informa Markets, where she oversees development of in-person, hybrid, and digital content for the CPHI Europe, CPHI North America, and Pharmapack Europe exhibitions and for CPHI Online.
Pharmaceutical Technology presents the Drug Solutions podcast, where the editors will chat with industry experts from across the pharmaceutical and biopharmaceutical supply chain. Join us as experts share insights into your biggest questions—from the technologies, to strategies, to regulations related to the development and manufacture of drug products.
Listen to this podcast on SoundCloud, Spotify, Google Podcasts, or Apple Podcasts.